SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-182535
Filing Date
2014-05-05
Accepted
2014-05-05 16:29:22
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d707537d10q.htm 10-Q 241369
2 EX-31.1 d707537dex311.htm EX-31.1 5987
3 EX-31.2 d707537dex312.htm EX-31.2 6047
4 EX-32 d707537dex32.htm EX-32 4543
  Complete submission text file 0001193125-14-182535.txt   2220253

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT itci-20140331.xml EX-101.INS 244896
6 XBRL TAXONOMY EXTENSION SCHEMA itci-20140331.xsd EX-101.SCH 23734
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20140331_cal.xml EX-101.CAL 30688
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20140331_def.xml EX-101.DEF 66276
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20140331_lab.xml EX-101.LAB 217181
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20140331_pre.xml EX-101.PRE 142640
Mailing Address 3960 BROADWAY NEW YORK NY 10032
Business Address 3960 BROADWAY NEW YORK NY 10032 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 14813832
SIC: 2834 Pharmaceutical Preparations